Skip to main content

Gagnon Securities LLC

SEC CIK
0001125725
Latest filing
Aug 4, 2026

Holdings in Q3 2021

Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.

Institution overview
Positions
112
+1 vs. Q2 2021
Portfolio value
$673.1M
−$31.2M (−4.4%) vs. Q2 2021
Filed
Nov 12, 2021
SEC
Holdings of Gagnon Securities LLC in Q3 2021
SecurityClassSharesValue% of portfolioShare changeActionHistory
ETWOE2open Parent Holdings, Inc.COM CL A1,563,571$17.7M2.6%+431,576+38.1%AddedHistory
FIVNFive9, Inc.COM132,152$21.1M3.1%+4,007+3.1%AddedHistory
AMRCAmeresco, Inc.CL A371,654$21.7M3.2%−114,198−23.5%ReducedHistory
EVBGEverbridge, Inc.COM149,655$22.6M3.4%+4,772+3.3%AddedHistory
BLBlackline, Inc.COM192,760$22.8M3.4%−4,900−2.5%ReducedHistory
LLLL Flooring Holdings, Inc.COM1,240,527$23.2M3.4%+4,320+0.3%AddedHistory
ISRGIntuitive Surgical IncCOM NEW23,341$23.2M3.4%−17−0.1%ReducedHistory
AOSLAlpha & Omega Semiconductor LtdSHS747,927$23.5M3.5%−7,989−1.1%ReducedHistory
ENSGEnsign Group, IncCOM382,305$28.6M4.3%−18,325−4.6%ReducedHistory
PCRXPacira BioSciences, Inc.COM570,643$32.0M4.7%+71,310+14.3%AddedHistory
ALSumisho Air Lease CorpCL A899,256$35.4M5.3%+11,254+1.3%AddedHistory
CDNACareDx, Inc.COM755,497$47.9M7.1%−6,243−0.8%ReducedHistory

Sold out since Q2 2021 (10)

Positions held at the end of Q2 2021 that are gone from this filing.

Positions of Gagnon Securities LLC sold out since Q2 2021
SecurityClassShares in Q2 2021Value in Q2 2021% of portfolio in Q2 2021History
CM Life Sciences Inc18978W208UNIT 09/01/2025656,269$10.3M1.5%–
CM Life Sciences II Inc125842203UNIT 02/25/2028761,193$10.2M1.5%–
CM Life Sciences III Inc125841205UNIT 04/30/2028468,907$5.13M0.7%–
Uranium Participation Corporat917017105COM148,149$654.0K0.1%–
CM Life Sciences Inc18978W109COM CL A38,117$534.0K0.1%–
Blue Prism Group PLCG1193C101COM NEW28,374$317.0K<0.1%–
DMTKDermTech, Inc.COM6,072$252.0K<0.1%History
CM Life Sciences Inc18978W117*W EXP 09/04/20226,984$124.0K<0.1%–
QUMUQumu CorpCOM35,999$104.0K<0.1%History
MNKTQKeenova Therapeutics plcStock218,143$63.0K<0.1%History